Sign in to view content

Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients

Henry A Leder, MD

Video
Published 2020

Related

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
Reduced Incidence of Post-Injection Endophthalmitis With Pre-filled Syringes
Daniel B. Roth, MD
On Demand Cases, Courses, and Papers
2020
The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Annual Meeting Talks
2021

Category: Socioeconomics

See more